Table 1 Characteristics of demographic data between propofol and sevoflurane groups

Age (yr)^a

55–70

42–71

0.49

Gender (male/female)

3/2

2/5

0.28

Body mass index (kg/m²)^a

24.8–29.7

21.5–30.1

0.36

ASA physical status (II/III)

3/2

5/2

0.68

Smoke history (yes/no)

3/2

2/5

0.28

Diabetes type2 (yes/no)

2/3

0/7

0.07

Arterial hypertension (yes/no)

1/4

1/6

0.79

Coronary artery disease (yes/no)

0/5

1/6

0.38

UICC tumor stage (Ia/Ib/IIa/IIb/IIIa/IIIb)

3/0/0/1/0/1

6/1/0/0/0/0

0.29

Duration of surgery (min)^a

150–240

160–225

0.25

Duration of one-lung ventilation (min)^a

120–210

130–195

0.21